19 October 2023
19 October 2023
Under the partnership, Walgreens will provide patient recruitment services to support the ongoing trial.
There are seven regimens in HEALEY ALS Platform Trials, with five completed and two trials recruiting patients at Phase III.
The study will focus on recruiting participants from groups across the UK and France.
Phesi has launched a free-of-charge service for sponsors that offers immediate protocol analysis for trials that may be struggling to meet their goals.
Jonathan Milner, founder and former CEO of Abcam, has responded to the ISS recommendation to vote in favour of the deal.
The detection of minimal residual disease by second-look laparoscopy is the primary endpoint of the study.
The study will initially assess the combination’s pharmacokinetics and tolerability.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
